PubMed · 15096242
Tissue factor and tissue factor pathway inhibitor.
Abstract
The classical 'cascade/waterfall' hypothesis formulated to explain in vitro coagulation organised the amplification processes into the intrinsic and extrinsic pathways. Recent molecular biology and clinical data indicate that tissue factor/factor-VII interaction is the primary cellular initiator of coagulation in vivo. The process of blood coagulation is divided into an initiation phase followed by a propagation phase. The discovery of tissue factor pathway inhibitor further supports the revised theory of coagulation. Tissue factor is also a signalling receptor. Recent evidence has shown that blood-borne tissue factor has an important procoagulant function in sepsis, atherosclerosis and cancer, and other functions beyond haemostasis such as immune function and metastases.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
G C Price, S A Thompson, P C A Kam. 2004. Tissue factor and tissue factor pathway inhibitor.. https://doi.org/10.1111/j.1365-2044.2004.03679.x. https://pubmed.health/record/pubmed%3A15096242/tissue-factor-and-tissue-factor-pathway-inhibitor
Citations retain the original authors and DOI and include this site’s record URL. If this discovery service contributed to your research, you can also cite PubMed Health by Indiciae: BibTeX · RIS.